Literature DB >> 17633016

TRAF3 and its biological function.

Jeannie Q He1, Gagik Oganesyan, Supriya K Saha, Brian Zarnegar, Genhong Cheng.   

Abstract

Tumor necrosis factor receptor associated factor 3 (TRAF3) is one of the most enigmatic members in the TRAF family that consists of six members, TRAF1 to 6. Despite its similarities with other TRAFs in terms of structure and protein-protein association, overexpression of TRAF3 does not induce activation of the commonly known TRAF-inducible signaling pathways, namely NF-kappaB and JNK. This lack of a simple functional assay in combination with the mysterious early lethality of the TRAF3-deficient mice has made the study of the biological function of TRAF3 challenging for almost ten years. Excitingly, TRAF3 has been identified recently to perform two seemingly distinct roles. Namely, TRAF3 functions as a negative regulator of the NF-kappaB pathway and separately, as a positive regulator of type I IFN production, placing itself as a critical regulator of both innate and adaptive immune responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17633016     DOI: 10.1007/978-0-387-70630-6_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  24 in total

1.  A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response.

Authors:  Suzanne Paz; Myriam Vilasco; Steven J Werden; Meztli Arguello; Deshanthe Joseph-Pillai; Tiejun Zhao; Thi Lien-Anh Nguyen; Qiang Sun; Eliane F Meurs; Rongtuan Lin; John Hiscott
Journal:  Cell Res       Date:  2011-01-04       Impact factor: 25.617

Review 2.  Molecular mechanism and function of CD40/CD40L engagement in the immune system.

Authors:  Raul Elgueta; Micah J Benson; Victor C de Vries; Anna Wasiuk; Yanxia Guo; Randolph J Noelle
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 3.  How do pleiotropic kinase hubs mediate specific signaling by TNFR superfamily members?

Authors:  Bärbel Schröfelbauer; Alexander Hoffmann
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 4.  Roles of TRAF3 in T cells: many surprises.

Authors:  Zuoan Yi; Alicia M Wallis; Gail A Bishop
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 5.  TLR3 immunity to infection in mice and humans.

Authors:  Shen-Ying Zhang; Melina Herman; Michael J Ciancanelli; Rebeca Pérez de Diego; Vanessa Sancho-Shimizu; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2013-01-03       Impact factor: 7.486

6.  Cdx2 Expression and Intestinal Metaplasia Induced by H. pylori Infection of Gastric Cells Is Regulated by NOD1-Mediated Innate Immune Responses.

Authors:  Naoki Asano; Akira Imatani; Tomohiro Watanabe; Jun Fushiya; Yutaka Kondo; Xiaoyi Jin; Nobuyuki Ara; Kaname Uno; Katsunori Iijima; Tomoyuki Koike; Warren Strober; Tooru Shimosegawa
Journal:  Cancer Res       Date:  2016-01-12       Impact factor: 12.701

7.  Sec13 is a positive regulator of VISA-mediated antiviral signaling.

Authors:  Tian Chen; Dandan Wang; Tao Xie; Liang-Guo Xu
Journal:  Virus Genes       Date:  2018-06-14       Impact factor: 2.332

8.  Nod1 Imprints Inflammatory and Carcinogenic Responses toward the Gastric Pathogen Helicobacter pylori.

Authors:  Giovanni Suarez; Judith Romero-Gallo; Maria B Piazuelo; Johanna C Sierra; Alberto G Delgado; M Kay Washington; Shailja C Shah; Keith T Wilson; Richard M Peek
Journal:  Cancer Res       Date:  2019-01-29       Impact factor: 12.701

9.  Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancer.

Authors:  Juan M Zapata; David Llobet; Maryla Krajewska; Sophie Lefebvre; Christina L Kress; John C Reed
Journal:  Blood       Date:  2008-12-12       Impact factor: 22.113

10.  Single amino acid substitutions confer the antiviral activity of the TRAF3 adaptor protein onto TRAF5.

Authors:  Peng Zhang; Anna Reichardt; Huanhuan Liang; Roghiyh Aliyari; David Cheng; Yaya Wang; Feng Xu; Genhong Cheng; Yingfang Liu
Journal:  Sci Signal       Date:  2012-11-13       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.